Real-time enrollment status for this glioblastoma clinical trial
Current Status
Suspended
Checked: April 17, 2026 at 3:43 AM UTC
| NCT Number | NCT06325683 |
| Recruiting Status | Suspended |
| Condition | Glioblastoma |
| Phase | Clinical Trial |
| Target Enrollment | 184 participants |
| Active Locations | 216 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | April 15, 2026 (2 days ago) |
As of April 17, 2026: Clinical trial NCT06325683 is currently suspended participants. This clinical trial study for glioblastoma is not currently accepting new participants at 216 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06325683 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 216 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06325683 was last updated 2 days ago (April 15, 2026). HelloStudys verifies this status automatically.